CX3CR1 and prostate carcinoma: An elevated expression level of its receptor, CX3CR1 (C-X3-C Motif Chemokine receptor 1), has been implicated in the development of PNI and earlier recurrence of numerous cancers, such as PC, gastric cancer, and prostate cancer (68–70).